3Danielsson N, Hoa DP, Thang NV, et al. Arch Dis Child Fetal Neonatal Ed, 2004,89 (6) : 546-550.
4Sharma RK, Marwaha N, Kumar P, et al.Effect of oral water soluble vitamin K on PIVKA-Ⅱ levels in newborns.Indian Pediatr, 1995, 32( 8): 863-867.
5Ulusahin N, Arsan S, Ertogan F.Effects of oral and intramuscular vitamin K prophylaxis on PIVKA-Ⅱ assay parameters in breastfed infants in Turkey.Turk J Pediatr, 1996, 38( 3): 295-300.
6Bakhshi S, Deorari AK, Roy S, et al.Prevention of subclinical vitamin K deficiency based on PIVKA-Ⅱ levels: oral versus intramuscular route.Indian Pediatr, 1996, 33( 12): 1040-1043.
7Motohara K, Endo F, Matsuda Ⅰ .Effect of vitamin K administration on acarboxy prothrombin( PIVKA-Ⅱ) levels in newborns.Lancet, 1985, 2( 8449): 242-244.
8McNinch AW, Tripp JH.Haemorrhagic disease of the newborn in the British Isles: two year prospective study.BMJ, 1991, 303( 6810): 1105-1109.
9Cornelissen EAM, Kolee LAA, De Abreu RA,et al.Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-Ⅱ, and clotting factors in breast fed infants.Arch Dis Child, 1992, 67( 10): 1250-1254.
10Hansen KN, Ebbesen R.Neonatal vitamin K prophylaxis in Denmark: three years' experience with oral administration during the first three months of life compared with one oral administration at birth.Acta Paediatr, 1996, 85( 10): 1137-1139.
